USP17L11

Across TCGA pan-cancer cohorts, USP17L11 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated USP17L11 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher USP17L11 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated USP17L11 expression acts as an unfavorable survival marker.

KIRC and OV are the cancer types where USP17L11 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.016	0.881	<.001	108	view →
OV	DFS	Tertile	II,III,IV	0.222	0.541	.038	54	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

USP17L11–KIRC (OS)

Open the KIRC breakdown →